$24.11
0.43 (+1.82%)
Myriad Genetics, Inc. (MYGN)
CAPS Rating:
Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.
Fool.com
The World's Greatest Investing Community
Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK